Analystreport

Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) had its price target raised by analysts at Cantor Fitzgerald from $36.00 to $38.00. They now have an "overweight" rating on the stock.

Corbus Pharmaceuticals Holdings, Inc.  (CRBP) 
Last corbus pharmaceuticals holdings, inc. earnings: 3/12 07:05 am Check Earnings Report
US:NASDAQ Investor Relations: corbuspharma.com